Photo of John C Jr. Burnett

View Scopus Profile

John C Jr. Burnett, MD

  • 36417 Citations
  • 94 Scopus h-Index
1975 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where John C Jr. Burnett is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles
Heart Failure Medicine & Life Sciences
Atrial Natriuretic Factor Medicine & Life Sciences
Natriuretic Peptides Medicine & Life Sciences
Brain Natriuretic Peptide Medicine & Life Sciences
Kidney Medicine & Life Sciences
C-Type Natriuretic Peptide Medicine & Life Sciences
Endothelins Medicine & Life Sciences
Dogs Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1975 2020

INTRARENAL REGULATION OF SODIUM EXCRETION

Burnett, J. C. J., Costello, E. C. & Boerrigter, G.

National Institutes of Health

4/1/87 → 3/31/20

Project: Research project

Sodium
Heart Failure
Atrial Natriuretic Factor
Kidney
Natriuretic Peptides

PHARMACOLOGY AND PHYSIOLOGY OF NTS ALPHA-ADRENOCEPTORS

Burnett, J. C. J., Terzic, A., Tancredi, R. & Galeno, T.

National Institutes of Health

7/1/75 → …

Project: Research project

National Heart, Lung, and Blood Institute (U.S.)
Research
Heart Failure
Research Personnel
Medicine

Small Molecule Discovery for Particulate Guanylyl Cyclase Receptor B Enhancers

Burnett, J. C. J. & Sangaralingham, S. J.

Project: Research project

Novel Peptide Therapeutics for Hypertension

Burnett, J. C. J.

Project: Research project

Novel Peptide Therapeutics for Cardiorenal Protection in Heart Failure

Burnett, J. C. J.

Project: Research project

Research Output 1979 2020

Reply: The Role of miRNAs and lncRNAs in ANP Production Downregulation in Heart Failure

Reginauld, S. H. & Burnett, J. C., Jan 2020, In : JACC: Heart Failure. 8, 1, 1 p.

Research output: Contribution to journal › Letter

Open Access
1 Citation (Scopus)

Atrial natriuretic peptide: A molecular target of novel therapeutic approaches to cardio-metabolic disease

Cannone, V., Cabassi, A., Volpi, R. & Burnett, J. C. J., Jul 1 2019, In : International journal of molecular sciences. 20, 13, 3265.

Research output: Contribution to journal › Review article

Open Access
metabolic diseases
Metabolic Diseases
Atrial Natriuretic Factor
peptides
aldosterone

Atrial natriuretic peptide, heart failure and the heart as an endocrine organ

Burnett, J. C., Jan 1 2019, In : Clinical chemistry. 65, 12, p. 1602-1603 2 p.

Research output: Contribution to journal › Comment/debate

3 Citations (Scopus)

C53: A novel particulate guanylyl cyclase B receptor activator that has sustained activity in vivo with anti-fibrotic actions in human cardiac and renal fibroblasts

Chen, Y., Zheng, Y., Iyer, S. R., Harders, G. E., Pan, S., Chen, H. H., Ichiki, T., Burnett, J. C. J. & Sangaralingham, S. J., May 1 2019, In : Journal of Molecular and Cellular Cardiology. 130, p. 140-150 11 p.

Research output: Contribution to journal › Article

C-Type Natriuretic Peptide
Cyclic GMP
Fibroblasts
Kidney
Neprilysin
2 Citations (Scopus)

Circulating Neprilysin in Patients With Heart Failure and Preserved Ejection Fraction

Lyle, M. A., Iyer, S. R., Redfield, M. M., Reddy, Y. N. V., Felker, G. M., Cappola, T. P., Hernandez, A. F., Scott, C. G., Burnett, J. C. & Pereira, N. L., Jan 1 2019, (Accepted/In press) In : JACC: Heart Failure.

Research output: Contribution to journal › Article

Neprilysin
Heart Failure
Confidence Intervals
Body Mass Index
Smoking